Skip to ContentSkip to Navigation
breed in kennis  -  sterk in techniek
Over ons Praktische zaken Waar vindt u ons drs. G.E. Legger

Publicaties

A multidisciplinary RNA-guided approach to complement genomic analysis of unsolved patients with an inborn error of immunity

Managing non-SCID T cell lymphopenia after TREC-based newborn screening

Impact of Interleukin-1 Blockade on the Development of Macrophage Activation Syndrome in Still Disease: Incidence and Diagnostic Validity of the EULAR/ACR/PRINTO 2016 MAS Classification Criteria

Long-term efficacy and safety of colchicine and anti-IL-1 blockers in FMF: results from the Eurofever multicenter observational study

AA amyloidosis in a father and daughter as complication of PSTPIP1-associated myeloid-related proteinemia inflammatory (PAMI) syndrome

Management of adult-onset Still's disease: evidence- and consensus-based recommendations by experts

Monitoring of Adverse Events and Safety in Autoinflammatory Diseases: Real-Life Data from the Eurofever Registry

More severe parotid gland histopathology in paediatric-onset than in adult-onset Sjögren's disease

Neurological phenotype of ADA2 deficient patients: a cohort study

Clinical Symptoms, Laboratory Parameters and Long-Term Follow-up in a National DADA2 Cohort

Sustainable Development Goals

SDG 3 – Goede gezondheid en welzijn

Meer informatie over de Sustainable Development Goals.